This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: Innovations of Xiang-Yang Han in Modified Reoviral Therapy
Introduction
Xiang-Yang Han is an accomplished inventor based in Bellaire, TX (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of hyperproliferative diseases. With a total of 2 patents, his work focuses on innovative therapies that utilize modified Reoviridae viruses.
Latest Patents
Xiang-Yang Han's latest patents revolve around modified reoviral therapy. The first patent details a pharmaceutical composition comprising a modified Reoviridae virus, which is conjugated to a hydroxylated hydrocarbon or a polycationic polymer. This modification aims to reduce the clearance of the composition and minimize its immunogenicity. Furthermore, the invention outlines methods for treating hyperproliferative diseases by administering an effective amount of the modified Reoviridae virus to patients.
Career Highlights
Xiang-Yang Han is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating various hyperproliferative conditions.
Collaborations
Xiang-Yang Han collaborates with Jeffrey Tarrand, contributing to the development of innovative therapeutic solutions.
Conclusion
Xiang-Yang Han's contributions to modified reoviral therapy represent a significant advancement in the treatment of hyperproliferative diseases. His innovative approach and dedication to research continue to pave the way for future developments in this critical area of medicine.